BigBio Communications Launches The BioCalendar, The Premier Industry Calendar for Life Science Conferences and Events

SAN FRANCISCO–(BUSINESS WIRE)–BigBio Communications, developer of the life science industry news aggregator Big4Bio, proudly announces the launch of The BioCalendar (TheBioCalendar.com), an exclusive event listing platform for the global healthcare and biopharmaceutical industry. The BioCalendar was created to be the comprehensive calendar and guide for healthcare and life science industry event attendees worldwide, and also […]

Read More

Spotlight Q&A: Outlook Therapeutics — Developing First Ophthalmic Formulation of Bevacizumab for FDA Approval

LaVoieHealthScience Client Spotlight Following is a Q&A with Lawrence Kenyon, President, CEO and CFO of Outlook Therapeutics (NASDAQ: OTLK), a late-stage clinical biotech company focused on developing the first FDA-approved ophthalmic formulation of bevacizumab-vikg to treat wet age-related macular degeneration (wet AMD) and other retinal diseases.  By way of background for our readers, age-related macular […]

Read More

Spotlight: Moving Towards a More Inclusive Life Sciences Industry

Get access to an ED&I toolkit from MassBio As our CEO, Tilton Little, was one of the 160+ life sciences CEOs that signed MassBio’s CEO Pledge for a More Equitable and Inclusive Life Sciences Industry, Big4Bio will work towards creating a more diverse life sciences industry. MassBio can help your company launch, analyze, and/or strengthen […]

Read More

Big4Bio-Area Companies Awarded NIH COVID-19 Test Contracts

From the NIH: “The National Institutes of Health is investing $248.7 million in new technologies to address challenges associated with COVID-19 testing (which detects SARS-CoV-2 coronavirus). NIH’s Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts to seven biomedical diagnostic companies to support a range of new lab-based and point-of-care tests that could significantly increase […]

Read More

Big4Bio Q&A: Dror Bashan, CEO of Protalix BioTherapeutics

LaVoieHealthScience Client Spotlight with Dror Bashan, CEO of Protalix BioTherapeutics Can you provide a brief overview of Protalix BioTherapeutics and its focus? Protalix BioTherapeutics is a unique biopharmaceutical company dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based expression. Protalix was the first company ever to gain FDA approval for […]

Read More

Spotlight: 3.0 University Place

“In many ways, this project (3.0 University Place) is the most responsive to the needs of Philly’s burgeoning biotech and advanced life sciences sector” – 2020 PIDC/Commerce Department Life Science Report   About 3.0 University Place: 3.0 University Place — a 250,000+ sq ft, life sciences-enabled building (commercial lab and office trophy building) with LEED […]

Read More

Spotlight: Sikich — A Formula for Life Science Success

Sikich LLP is a 1000 member business advisory firm that offers technology and accounting services to a broad array of companies. In operation for more than 35 years, about 10 years ago the company started offering its services to life sciences companies, tailored to fit their specific needs. Big4Bio editor Marie Daghlian recently met virtually […]

Read More

Spotlight: Explora BioLabs — Powering Your Science

Explora BioLabs provides preclinical, AAALAC-accredited vivarium space and related services to clients of all sizes and in all stages of development. With 150,000 square feet of space across 11 locations in biotech-dense communities, the company prides itself on providing clients the ability to initiate preclinical in vivo programs in as little as two weeks, with […]

Read More

Spotlight: Cerevance Raises $45 Million to Advance Therapeutics Against Novel CNS Targets

by Marie Daghlian Cerevance has raised $45 million in a series B financing to continue deploying its platform to identify novel therapeutic targets for central nervous system diseases, and advance a pipeline of therapies for Parkinson’s disease, Alzheimer’s disease, and neuroinflammation. New investors GV, Bill Gates, and Foresite Capital joined previous investors Takeda Ventures, the […]

Read More

Big4Bio:SFBay COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]

Read More

GigaGen Focuses Its Technology to Address COVID-19 Pandemic

by Marie Daghlian GigaGen announced that it is developing a recombinant polyclonal antibody therapy for the treatment of COVID-19, the pandemic coronavirus that has been sweeping the world and for which humans have no innate immunity. Based in South San Francisco, GigaGen spent the first seven years of its existence developing its single cell technology […]

Read More

RESI’s First Digital Conference Successful

by Marie Daghlian The global COVID-19 pandemic has changed life as we know it, severely curtailing local and global travel, and postponing or cancelling many conferences and meetings around the world. For the RESI conference organizer Life Science Nation (LSN), however, it has presented an opportunity to go digital, and in fact, after they made […]

Read More

Big4Bio:Philadelphia COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]

Read More

Big4Bio:Boston COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]

Read More